Structural Heart Program: Definition, Uses, and Clinical Overview

Structural Heart Program Introduction (What it is)

A Structural Heart Program is a coordinated clinical service focused on diseases of the heart’s valves and other “structural” parts of the heart.
It brings multiple specialists together to evaluate patients and plan procedures when needed.
It is commonly used in hospitals and heart centers that offer advanced imaging and catheter-based or surgical heart procedures.
It is designed to streamline evaluation, treatment selection, and follow-up for complex heart conditions.

Why Structural Heart Program used (Purpose / benefits)

A Structural Heart Program exists to address structural heart disease, meaning problems with the heart’s physical components rather than primarily rhythm (electrical) disorders or coronary artery blockages.

Common goals include:

• Accurate diagnosis and severity grading
  Valve narrowing (stenosis) and leakage (regurgitation) can be difficult to quantify. Programs typically standardize how imaging and clinical findings are interpreted.

• Risk stratification and treatment selection
  Many patients being considered for valve repair or replacement have multiple medical conditions. A structured, team-based approach helps estimate procedural risk and compare options.

• Symptom evaluation and functional assessment
  Shortness of breath, fatigue, chest discomfort, and fainting can have many causes. Structural programs often integrate imaging, exercise capacity assessment, and hemodynamic data to clarify whether symptoms match the structural problem.

• Access to advanced therapies
  Structural heart care often includes catheter-based interventions (performed through blood vessels) and surgical approaches. The program model helps match patients to the most appropriate pathway.

• Procedure planning and safety checks
  Many structural procedures require careful measurement of anatomy (for example, valve size, calcium distribution, or vascular access) and coordination across imaging, anesthesia, and procedural teams.

• Longitudinal follow-up
  Structural conditions often require ongoing surveillance, medication optimization (when applicable), and repeat imaging to monitor device function or disease progression.

Importantly, a Structural Heart Program is not a single test or procedure. It is an organized way of delivering care for a group of related conditions.

Clinical context (When cardiologists or cardiovascular clinicians use it)

A Structural Heart Program is typically involved when a patient has suspected or confirmed structural disease that may require specialized imaging, a procedure, or multidisciplinary decision-making. Common scenarios include:

• Suspected or confirmed aortic stenosis (narrowing of the aortic valve)
• Mitral regurgitation (leaky mitral valve), including primary (degenerative) and secondary (functional) causes
• Tricuspid regurgitation and other right-sided valve disorders
• Evaluation for transcatheter valve therapies (catheter-based repair or replacement)
• Assessment of congenital or acquired holes between chambers, such as ASD (atrial septal defect) or PFO (patent foramen ovale), when closure is being considered
• Consideration of left atrial appendage occlusion (a device-based strategy used in selected patients with atrial fibrillation when long-term anticoagulation is challenging)
• Evaluation and treatment of paravalvular leak (leak around a prior surgical or transcatheter valve)
• Complex cases where symptoms, imaging, and clinical findings do not align and a “heart team” review may clarify next steps
• Patients needing coordination between interventional cardiology, cardiac surgery, cardiac imaging, and anesthesia for procedural planning

Contraindications / when it’s NOT ideal

Because a Structural Heart Program is a care pathway rather than one intervention, “contraindications” usually relate to when program-based structural interventions are less suitable, when simpler care is sufficient, or when timing should be adjusted. Examples include:

• Conditions better managed by general cardiology without advanced procedural evaluation (for example, mild valve disease needing periodic monitoring)
• Unclear diagnosis where first-line evaluation (basic echocardiography and clinical assessment) has not yet been completed
• Active infection, especially bloodstream infection or endocarditis (infection involving heart valves), where elective device implantation or valve procedures may be deferred
• Anatomy not suitable for a specific catheter-based therapy, such as unfavorable valve size, calcification pattern, or inadequate vascular access (varies by clinician and case)
• Severe comorbid illness where an invasive procedure may not align with overall goals of care (varies by clinician and case)
• Inability to tolerate required imaging or procedural supports, such as contrast exposure, transesophageal echocardiography, or anesthesia (varies by clinician and case)
• Situations where surgery is clearly preferred or urgently required (for example, certain complex valve or aortic conditions), making a catheter-first pathway less applicable

A key point: suitability is often procedure-specific. A patient may be a poor candidate for one structural therapy but appropriate for another, depending on anatomy and clinical context.

How it works (Mechanism / physiology)

A Structural Heart Program “works” by combining cardiovascular physiology, high-quality imaging, and team-based decision-making to correct or reduce the impact of structural abnormalities.

Mechanism, physiologic principle, or measurement concept

Structural heart disease often disrupts normal blood flow and pressure relationships:

• Stenosis (narrowing) increases resistance to forward blood flow and can raise pressure upstream (for example, severe aortic stenosis increases left ventricular pressure load).
• Regurgitation (leakage) causes backward flow and volume overload (for example, mitral regurgitation increases left atrial and pulmonary venous pressures and can contribute to shortness of breath).
• Shunts (abnormal connections) allow blood to flow between chambers or vessels in unintended directions, affecting oxygenation and chamber size over time.
• Prosthetic valve problems (degeneration, thrombosis, pannus, or paravalvular leak) can recreate stenosis or regurgitation physiology.

Programs standardize how these problems are measured and staged using tools such as:

• Echocardiography (transthoracic and transesophageal) for valve function, gradients, and chamber size
• CT imaging for anatomical sizing, calcium assessment, and procedural planning (especially for transcatheter valves)
• Cardiac catheterization for pressure measurements and, when needed, coronary assessment
• MRI in selected cases for volumes, flow quantification, or tissue characterization (availability and use vary)

Relevant cardiovascular anatomy and tissue involved

Structural heart care most commonly centers on:

• Valves: aortic, mitral, tricuspid, and pulmonary valves
• Chambers: left ventricle (pump function), left atrium (pressure/volume effects), right-sided chambers in advanced valve disease
• Septum: atrial and ventricular septum (ASD/VSD/PFO considerations)
• Great vessels and access vessels: aorta and peripheral arteries/veins used to deliver catheters and devices
• Left atrial appendage: a small outpouching of the left atrium relevant to clot risk in atrial fibrillation

Time course, reversibility, and clinical interpretation

Structural interventions may offer:

• Immediate hemodynamic improvement (for example, reducing a valve gradient or regurgitant volume right away), while symptom improvement may take longer.
• Partial reversibility of remodeling, such as reduction in chamber size or pressures over weeks to months in some patients; the degree of reversibility varies by clinician and case.
• Need for surveillance, because valve disease can progress, and implanted devices or repaired valves require periodic assessment.

Some “properties” like a single drug’s onset/offset do not apply to a Structural Heart Program. The closest equivalent is the program’s ability to coordinate timely evaluation, careful selection of therapy, and consistent follow-up across the full course of disease.

Structural Heart Program Procedure overview (How it’s applied)

A Structural Heart Program typically applies a repeatable workflow from referral to follow-up. Exact steps vary by center and by the condition being evaluated.

1. Evaluation / exam
   – Symptom review (for example, exertional shortness of breath, chest discomfort, swelling, fainting)
   – Physical exam (murmurs, signs of fluid overload)
   – Review of prior imaging, procedures, and medical history

2. Baseline testing and imaging
   – Transthoracic echocardiogram is commonly a first-line structural test
   – Additional imaging (TEE, CT, MRI) based on the question being answered
   – Labs and functional assessment as needed (varies by clinician and case)

3. Risk assessment and “heart team” review
   – Discussion among interventional cardiology, cardiac surgery, imaging specialists, and anesthesia when appropriate
   – Clarification of goals: symptom relief, prevention of complications, or both (depends on condition)

4. Preparation
   – Procedure planning: access route, device sizing, anesthesia approach, imaging guidance
   – Medication review, including antithrombotic considerations (varies by clinician and case)

5. Intervention / testing (when indicated)
   – Catheter-based therapy, surgical therapy, or continued monitoring
   – Intra-procedural imaging and hemodynamic checks are common in many structural procedures

6. Immediate checks
   – Post-procedure imaging to confirm device position and function when relevant
   – Monitoring for rhythm issues, bleeding, vascular access complications, kidney function changes, or stroke-like symptoms (risk varies by procedure)

7. Follow-up
   – Clinic visit(s) and repeat echocardiography at intervals determined by the condition and device used
   – Ongoing management of contributing factors (blood pressure, heart failure therapy, atrial fibrillation management), often coordinated with the referring cardiologist

Types / variations

Structural Heart Programs differ by scope, staffing, and the therapies offered. Common variations include:

• Valve-focused programs
• Aortic valve disease pathways (often including evaluation for transcatheter or surgical replacement)
• Mitral valve repair/replacement pathways, including transcatheter edge-to-edge repair in selected patients

• Tricuspid valve evaluation programs, increasingly emphasizing imaging and emerging catheter-based options (availability varies by center)

• Device and closure programs

• Left atrial appendage occlusion evaluation and implantation pathways
• ASD/PFO closure pathways (patient selection varies by clinician and case)

• Paravalvular leak closure programs in centers with specialized imaging and device experience

• Imaging-integrated structural programs

• Strong emphasis on advanced echocardiography and cardiac CT for procedural planning

• 3D imaging workflows and standardized measurement protocols (implementation varies by center)

• Catheter-based vs surgical emphasis

• Some centers are predominantly catheter-based with surgical backup

• Others run truly hybrid models with shared decision-making and shared procedural planning

• Hybrid operating room (OR) / structural heart suite models

• Some programs perform procedures in cath labs, hybrid ORs, or dedicated structural suites depending on local resources and case complexity

Pros and cons

Pros:

• Coordinated, multidisciplinary evaluation for complex valve and structural conditions
• Standardized imaging and measurement approaches that can improve clarity of diagnosis
• Access to a broader range of therapies, including catheter-based and surgical options
• Procedure planning that integrates anatomy, symptoms, and overall health status
• Streamlined care pathway from referral through follow-up, reducing fragmentation
• Shared decision-making frameworks that clarify tradeoffs and expectations
• Often includes specialized nursing, coordinators, and rehab planning support (varies by center)

Cons:

• Not every patient needs program-level complexity; mild disease may be managed with routine cardiology follow-up
• Availability can be limited to larger centers, creating travel or scheduling burdens
• Workups may require multiple imaging tests, which can be time-consuming and resource-intensive
• Some evaluations involve invasive testing or anesthesia-supported imaging (varies by clinician and case)
• Differences in local expertise and device availability can affect which options are offered
• Insurance coverage and out-of-pocket costs can vary widely by region and plan
• For some conditions, evidence and guidelines may leave gray areas where recommendations differ among clinicians

Aftercare & longevity

Aftercare in a Structural Heart Program is typically focused on monitoring the heart’s function over time, checking device or repair performance when applicable, and managing the conditions that influence long-term outcomes.

Factors that commonly affect outcomes or “longevity” of results include:

• Severity and stage of the underlying disease at the time of treatment (earlier vs more advanced remodeling)
• Heart function and pulmonary pressures, which may influence symptom recovery and exercise tolerance
• Comorbidities such as chronic kidney disease, lung disease, diabetes, frailty, or vascular disease
• Rhythm disorders, particularly atrial fibrillation, which can affect symptoms and anticoagulation decisions
• Adherence to follow-up visits and repeat imaging schedules used to detect changes early (timing varies by clinician and case)
• Rehabilitation and functional recovery support, such as structured cardiac rehabilitation when appropriate and available
• Device or material durability, which can vary by material and manufacturer, and depends on the specific device type and patient factors
• Medication strategy after intervention, especially antithrombotic therapy when relevant; regimens vary by clinician and case

In general, structural interventions may reduce symptoms and improve hemodynamics, but they do not eliminate the need for ongoing cardiovascular care.

Alternatives / comparisons

A Structural Heart Program is one approach to organizing evaluation and treatment, not the only pathway. Alternatives depend on the condition and its severity.

Common comparisons include:

• Observation and monitoring vs intervention
  Mild or moderate valve disease is often monitored with periodic clinical visits and echocardiograms. Intervention is usually considered when disease becomes severe, symptoms develop, or heart function changes—exact thresholds vary by guideline, clinician, and case.

• Medication management vs structural procedure
  Medications can help manage consequences (for example, fluid overload in heart failure or rate control in atrial fibrillation) but typically do not “fix” a severely narrowed or severely leaking valve. Whether a procedure is appropriate depends on anatomy, symptoms, risk, and patient goals.

• Noninvasive testing vs invasive assessment
  Echocardiography and CT are noninvasive ways to assess structure and function. Cardiac catheterization provides direct pressure measurements and may be used when noninvasive results are inconclusive or when coronary assessment is needed (varies by clinician and case).

• Catheter-based vs surgical approaches
  Catheter-based procedures can reduce the need for open surgery in selected patients, but they are not suitable for all anatomies or disease mechanisms. Surgery may be preferred for certain valve pathologies, combined disease (multiple valves), or when other surgical repairs are needed concurrently.

• Local cardiology care vs referral to a specialized center
  Many patients can be managed locally with shared-care follow-up. Referral to a structural program is often helpful when advanced imaging, device therapies, or multidisciplinary planning is needed.

Structural Heart Program Common questions (FAQ)

Q: Is a Structural Heart Program the same as a cardiology clinic?
A Structural Heart Program is usually a specialized part of cardiology focused on valve and structural problems. It often includes a “heart team” with interventional cardiologists, cardiac surgeons, imaging specialists, and anesthesia support. A general cardiology clinic may manage many structural conditions, but complex cases often benefit from program-based coordination.

Q: Will the evaluation be painful?
Most initial evaluations involve clinic visits and noninvasive imaging like echocardiography, which is typically not painful. Some tests, such as transesophageal echocardiography or cardiac catheterization, can involve sedation or local anesthesia and may cause temporary discomfort. The exact experience varies by test and by center.

Q: Does being seen in a Structural Heart Program mean I will need a procedure?
Not necessarily. Many patients are referred for a second opinion on severity, symptoms, or timing. Some are best served by monitoring, medication optimization, or referral to another specialty, depending on findings.

Q: How long do results last after a structural heart procedure?
Durability depends on the underlying condition, the type of repair or replacement, and patient-specific factors. For implanted devices and valves, performance over time can vary by material and manufacturer. Most programs plan structured follow-up imaging to monitor function.

Q: Is care in a Structural Heart Program considered safe?
Structural procedures are performed in specialized environments with teams trained to manage complications, but no procedure is risk-free. Safety depends on the specific intervention, patient health status, and anatomy. Programs emphasize risk assessment and shared decision-making to weigh benefits and risks.

Q: How long is hospitalization and recovery?
This depends on whether care involves a catheter-based procedure, surgery, or no intervention at all. Catheter-based treatments often involve shorter hospital stays than open surgery, but length of stay varies by clinician and case. Recovery time is influenced by baseline health, complications, and rehab needs.

Q: Will I have activity restrictions afterward?
Restrictions depend on the procedure performed, access site, and overall recovery. Some patients have short-term limitations related to vascular access healing, while surgical patients may have longer restrictions. Your care team typically provides individualized instructions; recommendations vary by clinician and case.

Q: How much does evaluation or treatment cost?
Costs vary widely based on insurance coverage, hospital billing structure, imaging needs, and whether a procedure is performed. Structural evaluations can involve multiple advanced tests and specialist visits, which can affect total cost. Many centers have financial counseling services to help patients understand expected charges.

Q: Can I get a second opinion through a Structural Heart Program?
Yes. Structural programs commonly provide second opinions on valve severity, procedural candidacy, and the range of available options. Second-opinion reviews often include re-evaluating imaging quality and ensuring that symptoms and test results align.

Q: What should I expect at follow-up?
Follow-up commonly includes symptom review, physical examination, and repeat echocardiography at intervals based on the condition and any devices used. Programs often coordinate with a patient’s primary cardiologist for shared long-term care. The follow-up schedule varies by clinician and case.